Target intelligence / Profile preview

Sex-determining region Y protein (SRY)

Target
SRY
Molecular classification
Transcription factor, DNA-binding protein, SOX (SRY-like box) gene family
01

Overview

Sex-determining region Y protein (SRY) is a DNA-binding transcription factor encoded by the SRY gene on the Y chromosome and is crucial for initiating male sex determination in therian mammals[1][2]. SRY upregulates SOX9 expression in the bipotential gonad, triggering Sertoli cell formation, which leads to the development of testes and subsequent male differentiation[1][2][3][4][5][6]. In the absence or mutation of SRY, an XY individual can develop as phenotypically female, while aberrant presence or activation in XX individuals can result in male traits[1][3]. SRY acts primarily during early fetal development and belongs to the SOX (SRY-box) gene family, with its sequence-specific HMG domain mediating DNA binding and bending[1][5][6]. Mutations in SRY's HMG domain are a major cause of XY sex reversal and disorders of sex development in humans[1][3][6]. SRY is not considered a traditional therapeutic target, as its critical role is limited to development and not subject to pharmacological modulation[3][6].

Other names
Testis-determining factorTDFtestis-determining factorSRYsex-determining region Y proteinsex-determining region on Ytestis-determining factor on YSRXX1SRXY1TDY
02

Biological functions

Sex determinationInitiation of male gonad (testis) developmentRegulation of gene transcription (SOX9 upregulation)
03

Disease associations

Disorders of sex developmentSex reversal syndromes (e.g., XY females, XX males)Infertility related to sex determination disorders
04

Safety considerations

Mutations may result in sex reversal or disorders of sex developmentClinical impact limited to reproductive medicine and genetics, not drug targeting
05

Biomarkers

SRY gene presence for sex determination (karyotyping, genotyping)SRY mutations in patients with disorders of sex development

Beyond the preview

Go deeper on Sex-determining region Y protein (SRY).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sex-determining region Y protein (SRY).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call